Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19240722rdf:typepubmed:Citationlld:pubmed
pubmed-article:19240722lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:19240722lifeskim:mentionsumls-concept:C0677886lld:lifeskim
pubmed-article:19240722lifeskim:mentionsumls-concept:C0078058lld:lifeskim
pubmed-article:19240722lifeskim:mentionsumls-concept:C0164786lld:lifeskim
pubmed-article:19240722lifeskim:mentionsumls-concept:C1256770lld:lifeskim
pubmed-article:19240722lifeskim:mentionsumls-concept:C0812228lld:lifeskim
pubmed-article:19240722lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:19240722lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:19240722lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:19240722pubmed:issue6lld:pubmed
pubmed-article:19240722pubmed:dateCreated2009-3-18lld:pubmed
pubmed-article:19240722pubmed:abstractTextVascular endothelial growth factor (VEGF)-A inhibitors exhibit unseen high responses and toxicity in recurrent epithelial ovarian cancer suggesting an important role for the VEGF/VEGFR pathway. We studied the correlation of VEGF signalling and AKT/mTOR signalling. Using a tissue microarray of clinical samples (N=86), tumour cell immunohistochemical staining of AKT/mTOR downstream targets, pS6 and p4E-BP1, together with tumour cell staining of VEGF-A and pVEGFR2 were semi-quantified. A correlation was found between the marker for VEGFR2 activation (pVEGFR2) and a downstream target of AKT/mTOR signalling (pS6) (R=0.29; P=0.002). Additional gene expression analysis in an independent cDNA microarray dataset (N=24) showed a negative correlation (R=-0.73, P<0.0001) between the RPS6 and the VEGFR2 gene, which is consistent as the gene expression and phosphorylation of S6 is inversely regulated. An activated tumour cell VEGFR2/AKT/mTOR pathway was associated with increased incidence of ascites (chi(2), P=0.002) and reduced overall survival of cisplatin-taxane-based patients with serous histology (N=32, log-rank test, P=0.04). These data propose that VEGF-A signalling acts on tumour cells as a stimulator of the AKT/mTOR pathway. Although VEGF-A inhibitors are classified as anti-angiogenic drugs, these data suggest that the working mechanism has an important additional modality of targeting the tumour cells directly.lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:languageenglld:pubmed
pubmed-article:19240722pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:citationSubsetIMlld:pubmed
pubmed-article:19240722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19240722pubmed:statusMEDLINElld:pubmed
pubmed-article:19240722pubmed:monthMarlld:pubmed
pubmed-article:19240722pubmed:issn1532-1827lld:pubmed
pubmed-article:19240722pubmed:authorpubmed-author:DirixL YLYlld:pubmed
pubmed-article:19240722pubmed:authorpubmed-author:van DamP APAlld:pubmed
pubmed-article:19240722pubmed:authorpubmed-author:Van der...lld:pubmed
pubmed-article:19240722pubmed:authorpubmed-author:VermeulenP...lld:pubmed
pubmed-article:19240722pubmed:authorpubmed-author:HellemanJJlld:pubmed
pubmed-article:19240722pubmed:authorpubmed-author:TjalmaW A AWAlld:pubmed
pubmed-article:19240722pubmed:authorpubmed-author:BernsE M J...lld:pubmed
pubmed-article:19240722pubmed:authorpubmed-author:TrinhX BXBlld:pubmed
pubmed-article:19240722pubmed:authorpubmed-author:Van den...lld:pubmed
pubmed-article:19240722pubmed:authorpubmed-author:Van LaereS...lld:pubmed
pubmed-article:19240722pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19240722pubmed:day24lld:pubmed
pubmed-article:19240722pubmed:volume100lld:pubmed
pubmed-article:19240722pubmed:ownerNLMlld:pubmed
pubmed-article:19240722pubmed:authorsCompleteYlld:pubmed
pubmed-article:19240722pubmed:pagination971-8lld:pubmed
pubmed-article:19240722pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
pubmed-article:19240722pubmed:meshHeadingpubmed-meshheading:19240722...lld:pubmed
More...